GPT Healthcare Ltd Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 3 Aug 2026 | Healthcare Services | Market Cap: ₹1.3K Cr
The company is guiding for a 15% overall top-line growth for the current year. GPT Healthcare expects overall top-line growth around 15% with new hospital additions.
From GPT Healthcare Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹151
Market Cap
₹1.3K Cr
P/E Ratio
27.1
How does GPT Healthcare Ltd rank in Healthcare Services?
Compare GPT Healthcare Ltd against every Healthcare Services company this quarter on revenue, margins and earnings-call signals.
GPT Healthcare Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹126 Cr, net profit ₹15 Cr.
Full financials →📊 Revenue & Sales Performance
- →The company is guiding for a 15% overall top-line growth for the current year.
- →Growth rates of 20%-25% are unlikely as mature hospitals typically grow at 6%-8%; 15% growth is expected with new hospital additions (Page 10).
- →Base business growth excluding new hospitals like Raipur is around 6%-6.5%, on track with previous commitments (Page 6).
- →Ramp-up of new hospitals like Raipur is anticipated; occupancy expected to reach 25%-35% over the year with EBITDA margins of 8%-10% (Pages 9-10).
- →Addition of Jamshedpur hospital expected by end of FY '27, incurring INR4-5 crores losses initially but contributing to growth long-term (Page 9).
- →Strategies like optimizing department mix and shortening average length of stay (from 5.8 to 4.3 days) aim to improve throughput and revenues (Page 8).
- →ARPOB growth guidance of 5%-6% driven by case mix and price increases supports revenue growth (Page 5).
📈 Profitability & Margins
- →GPT Healthcare expects overall top-line growth around 15% with new hospital additions.
- →Mature hospitals typically experience 6-8% growth; newer hospitals have higher growth rates initially.
- →EBITDA margins for FY '26 projected around 20-22% (including other income), with mature hospitals at ~25% margin before HO costs.
- →Raipur hospital expected to reach breakeven monthly around 12-15 months at ~25-35% occupancy, with FY '27 EBITDA margin of 8-10%.
- →New hospital Jamshedpur to be commissioned by end FY '27, expecting INR4-5 crores loss initially.
- →ARPOB (average revenue per occupied bed) growth guided at 5-6% annually through rate revisions and improved case mix.
- →EBITDA losses of about INR9-10 crores expected per full year for newly commissioned hospitals initially but improve over time.
- →The company aims to become a 1,000-bed hospital chain within two years, indicating steady operational scaling and profit growth.
🏗️ Capital Expenditure Plans
- →GPT Healthcare Limited has signed an MOU for a new hospital in Jamshedpur with a planned capacity of 150 beds.
- →Estimated investment outlay for the Jamshedpur hospital is INR 70 crores.
- →The Jamshedpur hospital is expected to be commissioned by the end of Q3 FY '27.
- →The company is actively evaluating multiple cities in Eastern India for inorganic or organic growth opportunities, including Varanasi, Patna, and Cuttack.
- →Preference for asset-light models (leased land), but willing to invest in land if the location is strategic.
- →The company aims to become a 1,000-bed hospital chain over the next two years, reflecting ongoing expansion plans.
- →No specific new capex amounts disclosed besides the Jamshedpur project investment.
💰 Fundraising & Capital Structure
- →The transcript from the conference call does not mention any current or planned fundraising through debt or equity.
- →There is no discussion about raising capital through new debt instruments or equity offerings.
- →The company is focusing on organic growth, expansion via new hospitals (e.g., Jamshedpur), and possible acquisitions or greenfield projects predominantly in Eastern India's Tier 2 cities.
- →Investment plans involve deploying capital for new hospital launches and refurbishments, but no explicit comments on funding sources or fundraising strategies were provided.
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were GPT Healthcare Ltd Q2 FY26 results?
The company is guiding for a 15% overall top-line growth for the current year. GPT Healthcare expects overall top-line growth around 15% with new hospital additions.
What is GPT Healthcare Ltd share price analysis?
GPT Healthcare Ltd currently shows a neutral. The stock trades at a P/E of 27.1 with a market cap of ₹1,281 Cr. Investors should review the full earnings analysis for detailed insights.
Is GPT Healthcare Ltd planning capital expenditure?
GPT Healthcare Limited has signed an MOU for a new hospital in Jamshedpur with a planned capacity of 150 beds.
Keep GPT Healthcare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.